daclatasvir

interferon alpha 1 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30848363 Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan. 2019 Aug 2
2 28815329 Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study. 2018 Apr 2
3 26733671 Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα. 2017 Apr 2
4 27890790 Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B. 2017 Mar 1
5 25904097 The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay. 2016 Jan 1
6 26440999 Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b. 2016 Mar 1
7 26574180 Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients. 2016 Jul 1
8 26760453 Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease. 2016 Apr 24 1
9 27388424 Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals. 2016 Jul 7 1
10 27750228 Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type C. 2016 1
11 25529083 How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals. 2015 Jan 2
12 25704315 Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C. 2015 Dec 1
13 25764674 [JSH guidelines for the management of hepatitis C virus infection (version 3)]. 2015 Feb 3
14 26549010 Daclatasvir for the treatment of chronic hepatitis C. 2015 4
15 25059552 Efficacy of daclatasvir in hepatitis C virus. 2014 Sep 1
16 22706796 Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. 2012 Sep 2